14:32 03.10.2008, Vicriviroc is a CCR5 inhibitor currently available
Vicriviroc is a CCR5 inhibitor currently available. Results of studies show that its use is safe. In particular, these studies showed that treatment with the drug did not increase..
14:30 03.10.2008, Raltegravir is a new drug
Raltegravir is a new drug in the armamentarium of clinicians treating HIV especially drug resistant HIV. Recently researchers have found that Raltegravir is a safe and effective drug
14:28 03.10.2008, What to start treatment with--Truvada outperforms Kivexa when used with a boosted-PI NAM
British HIV treatment guidelines recommend that people starting HIV treatment for the first time should do so with a combination of drugs that includes efavirenz with either...
14:25 03.10.2008, Advantages to starting at a CD4 cell count of 500 from NAM
It is recommended that persons HIV+ start HIV treatment when their CD4 count is around 350. This is the recommendation of many countries, but not the USA.